Bayer(BAY)
Bayer AG (/ˈbaɪ.ər/, commonly pronounced /ˈbeɪər/; German: [ˈbaɪɐ]) is a German multinational pharmaceutical and biotechnology company and one of the largest pharmaceutical companies in the world. Headquartered in Leverkusen, Bayer's areas of business include pharmaceuticals; consumer healthcare products, agricultural chemicals, seeds and biotechnology products. The company is a component of the Euro Stoxx 50 stock market index.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Actron | Ketoprofen | 1995-10-06 | ||
| Adalat | Nifedipine | 1985-11-27 | ||
| Adempas | Riociguat | 2013-10-08 | 2026-2034 | |
| Aleve | Diphenhydramine, Naproxen, Pseudoephedrine | 2014-01-17 | 2025-2026 | |
| Aliqopa | Copanlisib | 2017-09-14 | 2024-2032 | |
| Angeliq | Drospirenone, Estradiol | 2005-09-28 | 2024-2037 | |
| Angiovist | Diatrizoate, Diatrizoate meglumine | 1982-09-23 | — | |
| Antagonate | Chlorpheniramine | 1982-01-01 | 2024-2032 | |
| Astepro | Azelastine | 2021-06-17 | 2023-2028 | |
| Avelox | Moxifloxacin | 1999-12-10 | 2029 |
1
2
3
4
5
6
...
11
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||
1
2
3
4
5
6
...
14
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use